Ciappenelli to replace Healey at Sepracor

Sepracor appointed Rob Ciappenelli to replace Tim Healey as head of its CNS portfolio, which includes the company’s Lunesta franchise, according to reports and sources close to the company.

Matthew Arnold

February 1, 2007

5:00 am

Sepracor appointed Rob Ciappenelli to replace Tim Healey as head of its CNS portfolio, which includes the company’s Lunesta franchise, according to reports and sources close to the company. Sepracor declined to confirm the appointment, saying it was against corporate policy.

From the February 01, 2007 Issue of MM+M - Medical Marketing and Media

From Our Partners

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

Partner Content

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

The evolution of patient needs and rising consumer expectations are shaping a new era in healthcare — one that calls for a paradigm shift in the pharmaceutical industry's approach to patient support.

Omnichannel activation without omniburden

Partner Content

Omnichannel activation without omniburden

Explore solutions for practically implementing omnichannel approaches into your go-to-market activation.

Taking a patient-centric approach to privacy

Partner Content

Taking a patient-centric approach to privacy

This podcast will explore ways to deliver tailored content that activates, educates and empowers patients while prioritizing privacy and consent.

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.